MedPath

Double-Blind, Placebo-Controlled Study for the Effect of Daily Ingestion of the Plum Extract on the Improvement of Blood Pressure and Blood Flow

Phase 3
Conditions
Healthy adults
Registration Number
JPRN-UMIN000017917
Lead Sponsor
Hokkaido Information University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
52
Inclusion Criteria

Not provided

Exclusion Criteria

1. Subjects who are under treatment and medication for hypertension. 2. Subjects with serious cerebrovascular, cardiac, hepatic, renal, and / or gastrointestinal diseases, or affected with an infectious disease which is required to report to the authorities 3. Subjects who have a major surgical history related to digestive system such as gastrectomy, gastrorrhaphy, enterectomy, etc. 4. Subjects with unusually high and/or low blood pressure or abnormal hematological data 5. Subjects with serious anemia 6. Pre- or post-menopausal subjects having complaints of obvious physical changes 7. Subjects who are at risk of having allergic reactions to drugs or foods (especially plum) 8. Subjects regularly take medicine, functional foods and/or supplements ( peptide, acetic acid, GABA, geniposidic acid, flavonoids, sesamin, chlorella, olive leaves, garlics, dietary fiber, tomatoes, folic acid, etc.) which would affect the blood pressure. 9. Heavy smokers, alcohol addicts or subjects with irregular lifestyle 10. Subjects who donate either 400ml whole blood within 12 weeks or 200ml whole blood within 4 weeks or blood components within 2 weeks prior to this study. 11. Subjects who are pregnant or expected to be pregnant, or lactating during the study 12. Subjects who participate in other clinical trials within the last one month prior to the current clinical trial 13. Any other medical reasons judged by the principal investigator

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
systolic pressure and diastolic pressure (hospital pressure and home pressure) , peripheral blood flow
Secondary Outcome Measures
NameTimeMethod
T-Cho, HDL-Cho, LDL-Cho, TG, fasting plasma glucose, HbA1c, hs-CRP, adiponectin, platelet aggregation, defecation frequency, VAS questionnaire
© Copyright 2025. All Rights Reserved by MedPath